Researchers at University College London (UCL) have discovered that MRI scans can detect early signs of lamin heart disease, a life-threatening genetic condition, even when standard tests show no abnormalities. Published in JACC: Cardiovascular Imaging, the study highlights MRI’s potential to improve risk predictions and guide critical treatment decisions, such as implantable defibrillator placement or heart transplants.
Lamin heart disease, caused by mutations in the LMNA gene, disrupts heart function and often leads to dangerous arrhythmias. While rare, it is frequently undiagnosed, affecting 1 in 5,000 people. Current risk assessments rely on electrocardiograms (ECGs) and echocardiograms, which may miss early signs of damage.
The UCL team analyzed MRI data from 187 participants, including patients with lamin disease, non-genetic heart conditions, and healthy volunteers. They found that MRI could identify inflammation, scarring, and subtle heart dysfunction in LMNA mutation carriers whose hearts appeared normal on standard tests.
Dr. Gaby Captur, the study’s senior author, emphasized the limitations of current tools: “Genetics alone cannot predict disease progression. Our findings show MRI’s potential to refine risk estimates, especially for women, who are often underserved by existing methods.”
Lead author Dr. Cristian Topriceanu added that MRI could also monitor responses to emerging gene therapies and identify patients in early disease stages who might benefit most from treatment.
- Dr. Gaby Captur: “Predicting risk is important because it determines which patients receive defibrillators. Currently, 7 out of 10 recipients don’t benefit.”
- Dr. Cristian Topriceanu: “MRI picks up signals other tests miss, like tissue scarring and inflammation, offering a clearer picture of disease progression.”
The study underscores MRI’s role as a gold-standard tool for managing lamin heart disease, enabling earlier detection and personalized care. Further research with larger patient groups is needed to validate these findings, but the results could transform how this high-risk condition is monitored and treated.
Add comment